TUESDAY, Nov. 9, 2021 (HealthDay News) — “Ultra-low” doses of the drug rituximab may be enough to keep some patients’ rheumatoid arthritis under control for several years, a new, preliminary study suggests. Researchers found that among 118 patients, low doses of the drug were comparable to standard ones in controllingContinue Reading

FRIDAY, Nov. 5, 2021 (HealthDay News) — At a veterinary clinic in the United Kingdom, the staff noticed a sudden and atypical increase in cats and dogs who were experiencing myocarditis, an inflammation of the heart muscle. Was it a coincidence that these animals were showing up severely ill fromContinue Reading

WEDNESDAY, Nov. 3, 2021 (HealthDay News) — Researchers may have unearthed a surprising risk factor for often-fatal brain bleeds: Sleepless nights. In a study of about 70,000 adults, researchers found that people with a genetic predisposition to insomnia were at somewhat higher risk of a brain aneurysm. An aneurysm isContinue Reading

TUESDAY, Nov. 2, 2021 (HealthDay News) — Nearly one-third of older U.S. adults visit at least five different doctors each year — reflecting the growing role of specialists in Americans’ health care, a new study finds. Over the past 20 years, Americans on Medicare have been increasingly seeing specialists, researchersContinue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2Continue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Do you like your burgers well done with a side of plastic? Probably not. But a new study suggests that fast food often comes with a sizable helping of plastic-softening chemicals that could potentially lead to hormone disruption, infertility and learning disabilities. AtContinue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows. Researchers found that the shorter regimen — given over five weeks, instead of seven — did not raise patients’ odds of lasting side effects.Continue Reading